StockNews.AI
TWST
StockNews.AI
106 days

Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

1. Twist Bioscience reported Q2 fiscal 2025 financial results. 2. The company continues to grow in the life sciences sector.

Earnings
-12.79%Current Return
VS
-1.4%S&P 500
$39.2405/05 07:28 AM EDTEvent Start
$34.2205/06 02:07 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The mid-cap growth trajectory in healthcare suggests potential financial stability and investor interest. Historical performance indicates positive correlation between quarterly results and stock price movement.

How important is it?

Earnings announcements are critical for mid-cap firms like TWST and often reflect operational performance and growth potential, making this information highly relevant.

Why Short Term?

Investors often react to quarterly earnings quickly, influencing share prices in the immediate future. Previous earnings reports have shown significant short-term volatility following announcements.

Related Companies

AMGNGILDILMN
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the second quarter fiscal 2025 ended March 31, 2025. Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal second quarter 2025 earnings report a.

Related News